Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/20/2012US8313927 Ucp4
11/20/2012US8313924 Muteins of tear lipocalin and methods for obtaining the same
11/20/2012US8313920 High-throughput assay for evaluating dipeptidyl peptidase I activity
11/20/2012US8313914 Compositions and methods for modulation of cell migration
11/20/2012US8313912 Cancer specific oligosaccharide sequences and use thereof
11/20/2012US8313900 Isolated DNA directed 50kD regulatory subunit (POLD2) genomic polynucleotide fragments from chomosome 7 and their uses
11/20/2012US8313899 Isolated snare YKT6 genomic polynucleotide fragments from chomosome 7 and their uses
11/20/2012US8313767 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
11/20/2012US8313764 Wound healing device
11/20/2012US8313744 Composition for the prevention and treatment of absence seizures comprising PKC agonist as an effective ingredient
11/20/2012US8313739 Use of truncated cysteine IL28 and IL29 Mutants to treat cancers and autoimmune disorders
11/20/2012US8313731 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
11/20/2012CA2692358C Recombinant human interferon-like proteins
11/20/2012CA2633171C Antibodies against tumor-associated antigenic target (tat) polypeptides
11/20/2012CA2584406C Lecithinized superoxide dismutase composition and a process for its production
11/20/2012CA2560278C Modified bouganin proteins, cytotoxins and methods and uses thereof
11/20/2012CA2490735C Liquid preparation comprising oligopeptides and etherified cyclodextrin
11/20/2012CA2486944C Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
11/20/2012CA2482929C Tuberculin immunoadjuvant
11/20/2012CA2448796C Vaccine against the nile fever virus
11/20/2012CA2421580C Discrimination between gnrh-i and gnrh-ii
11/20/2012CA2398983C Pharmaceutical composition to prevent tissue damage due to arterial blood flow failure
11/20/2012CA2380331C Multiple cytokine-antibody complexes
11/20/2012CA2376978C Compositions and methods for treatment of sexual dysfunction
11/20/2012CA2335362C Use of a dipeptide for stimulating repair processes
11/20/2012CA2265915C Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
11/15/2012WO2012155124A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012WO2012155114A1 Peptides derived from uroguanylin and their use in gastrointestinal disorders
11/15/2012WO2012155108A1 Treatments for disorders using guanylate cyclase c agonists
11/15/2012WO2012155107A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
11/15/2012WO2012155101A1 Treatments for gastrointestinal disorders
11/15/2012WO2012155053A1 Modified biotin-binding protein, fusion proteins thereof and applications
11/15/2012WO2012155027A1 Wound debridement compositions containing seaprose and methods of wound treatment using same
11/15/2012WO2012155007A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
11/15/2012WO2012154759A2 Genetically engineered growth factor variants
11/15/2012WO2012154756A2 Delaying the progression of diabetes
11/15/2012WO2012154685A1 Canfosfamide monotherapy for treating multiple myeloma
11/15/2012WO2012154684A2 Method of preventing development of psoriatic lesions
11/15/2012WO2012154587A2 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
11/15/2012WO2012154574A1 Compositions and methods for treating diabetes
11/15/2012WO2012154474A2 Biomaterial composite composition and method of use
11/15/2012WO2012154215A1 Cns antigen-specific b cell, t cell and antibody assays and their uses in diagnosis and treatment of multiple sclerosis
11/15/2012WO2012154109A1 Self -aggregating antimicrobial cyclic peptides comprising beta - tri substituted amino acid residues
11/15/2012WO2012154078A1 Antimicrobially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012154077A1 Pharmaceutical composition for the treatment of tuberculosis and other infections, and method for producing said composition
11/15/2012WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant
11/15/2012WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell
11/15/2012WO2012153576A1 Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube
11/15/2012WO2012153337A2 Anti-microbial peptides and uses of same
11/15/2012WO2012153333A1 Regeneration and repair of mesenchymal tissue using amelogenin
11/15/2012WO2012153302A1 Antipyretics to enhance tolerability of vesicle-based vaccines
11/15/2012WO2012153191A1 Ncor1 is a physiological modulator of muscle mass and oxidative function
11/15/2012WO2012153125A1 Novel compounds and methods for use in medicine
11/15/2012WO2012153071A2 Polysaccharides having a variable degree of functionalization
11/15/2012WO2012152970A1 Method for the diagnosis of ischemic stroke
11/15/2012WO2012152953A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/15/2012WO2012152882A1 Methods and pharmaceutical compositions for the treatment of autoimmune diseases
11/15/2012WO2012152739A1 Compounds with thioredoxin-like fold domain for the treatment of degenerative disorders
11/15/2012WO2012152707A1 Microemulsions
11/15/2012WO2012152211A1 Tnf-α short peptide associated with apoptosis or necrosis and use thereof
11/15/2012WO2012152063A1 Novel biomarker of hcc, rarres2
11/15/2012WO2012151718A1 Pig myostatin gene promoter and its applications
11/15/2012WO2012151609A1 Method of treatment and prophylaxis of pathologies of the bone
11/15/2012WO2012129394A9 Methods and compositions for the treatment of cancer
11/15/2012WO2012129077A3 Peptides for suppressing inflammation
11/15/2012WO2012125830A3 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
11/15/2012WO2012123519A3 Human insulin analogues and derivatives comprising cysteine substitutions
11/15/2012WO2012120038A3 A polypeptide comprising n-terminal fragment of a cystatin for use in diagnosing and/or treating sterility
11/15/2012WO2012107567A3 Detection and removal of misfolded proteins/peptides
11/15/2012WO2012088116A3 Glucagon analogs exhibiting gip receptor activity
11/15/2012WO2012073111A3 Methods and compositions for monitoring phagocytic activity
11/15/2012WO2012070008A3 Recombinant proteins with a selective inactivation activity on target proteins
11/15/2012WO2012028524A3 Method for producing a tetranectin-apolipoprotein a-i lipid particle, the lipid particle itself and its use
11/15/2012WO2011120474A8 Method for inhibiting hiv replication in mammal and human cells
11/15/2012WO2011066971A3 Transdermal therapeutic system for the administration of peptides
11/15/2012US20120289981 Sericin extracted fabrics
11/15/2012US20120289932 Device and method for combining a treatment agent and a gel
11/15/2012US20120289472 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289469 Methods and compositions for maintaining active agents in intra-articular spaces
11/15/2012US20120289468 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
11/15/2012US20120289467 Compositions and Methods Utilizing Fibrin Beta Chain Fragments
11/15/2012US20120289466 Glucagon-like-peptide-2 (glp-2) analogues
11/15/2012US20120289465 Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases
11/15/2012US20120289464 Angiogenically effective unit dose of fgf-2 and method of use
11/15/2012US20120289463 Compositions and Methods for Promoting Epithelialization and Wound Closure
11/15/2012US20120289462 Insulin preparation
11/15/2012US20120289461 Protein synthesis promoter
11/15/2012US20120289460 Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
11/15/2012US20120289459 Antiviral peptides from african swine fever virus which prevent the binding of the virus to dlc8
11/15/2012US20120289458 Treatment of influenza virus infection
11/15/2012US20120289457 Peptide oligonucleotide conjugates
11/15/2012US20120289456 Antimicrobial protein compositions and uses thereof
11/15/2012US20120289455 Monocarbams
11/15/2012US20120289454 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012US20120289453 Novel glp-1 compounds
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288943 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/2012US20120288942 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 3163